Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of DLBS3233 in the Treatment of Subjects With New Onset of Type 2 Diabetes Mellitus

NCT01645332 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT01645332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01645332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of DLBS3233 in the Treatment of Subjects With New Onset of Type 2 Diabetes Mellitus
Lead sponsor
Dexa Medica Group
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
September 30, 2014
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new onset, type-2-diabetes mellitus